NO173298C - Anvendelse av karbohydratforbindelse med virusbindende egenskaper for in vitro diagnose av virusinfeksjoner eller for fremstilling eller isolering av viruspartikler eller virusoverflatekomponenter - Google Patents

Anvendelse av karbohydratforbindelse med virusbindende egenskaper for in vitro diagnose av virusinfeksjoner eller for fremstilling eller isolering av viruspartikler eller virusoverflatekomponenter

Info

Publication number
NO173298C
NO173298C NO863646A NO863646A NO173298C NO 173298 C NO173298 C NO 173298C NO 863646 A NO863646 A NO 863646A NO 863646 A NO863646 A NO 863646A NO 173298 C NO173298 C NO 173298C
Authority
NO
Norway
Prior art keywords
virus
isolation
preparation
viral infections
binding properties
Prior art date
Application number
NO863646A
Other languages
English (en)
Norwegian (no)
Other versions
NO863646D0 (no
NO173298B (no
NO863646L (no
Inventor
Karl-Anders Karlsson
Erling Norrby
Goeran Wadell
Original Assignee
Symbicom Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symbicom Ab filed Critical Symbicom Ab
Publication of NO863646D0 publication Critical patent/NO863646D0/no
Publication of NO863646L publication Critical patent/NO863646L/no
Publication of NO173298B publication Critical patent/NO173298B/no
Publication of NO173298C publication Critical patent/NO173298C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18811—Sendai virus
    • C12N2760/18851—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
NO863646A 1985-01-14 1986-09-12 Anvendelse av karbohydratforbindelse med virusbindende egenskaper for in vitro diagnose av virusinfeksjoner eller for fremstilling eller isolering av viruspartikler eller virusoverflatekomponenter NO173298C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK17885A DK17885D0 (da) 1985-01-14 1985-01-14 Antiviralt middel
PCT/DK1986/000007 WO1986003971A1 (en) 1985-01-14 1986-01-13 Antiviral agents

Publications (4)

Publication Number Publication Date
NO863646D0 NO863646D0 (no) 1986-09-12
NO863646L NO863646L (no) 1986-11-14
NO173298B NO173298B (no) 1993-08-16
NO173298C true NO173298C (no) 1993-11-24

Family

ID=8090653

Family Applications (1)

Application Number Title Priority Date Filing Date
NO863646A NO173298C (no) 1985-01-14 1986-09-12 Anvendelse av karbohydratforbindelse med virusbindende egenskaper for in vitro diagnose av virusinfeksjoner eller for fremstilling eller isolering av viruspartikler eller virusoverflatekomponenter

Country Status (11)

Country Link
US (2) US4859769A (de)
EP (1) EP0207984B1 (de)
JP (1) JPS62502260A (de)
CN (1) CN86100608A (de)
AU (1) AU580136B2 (de)
DK (1) DK17885D0 (de)
FI (1) FI93227C (de)
IE (1) IE59036B1 (de)
IL (1) IL77603A (de)
NO (1) NO173298C (de)
WO (1) WO1986003971A1 (de)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5534553A (en) * 1987-06-12 1996-07-09 Hoerrmann; Wilhelm Drug containing fatty amino alcohols or derivatives thereof
DE3819870A1 (de) * 1987-06-12 1988-12-29 Hoerrmann Wilhelm Arzneimittel auf der basis von fett-amino-alkoholen
US5344870A (en) * 1987-12-02 1994-09-06 Alberta Research Council Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation
US5079353A (en) * 1987-12-02 1992-01-07 Chembiomed, Ltd. Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation
WO1989008499A1 (en) * 1988-03-17 1989-09-21 Nippon Fine Chemical Co., Ltd. Liposome
IT1235011B (it) * 1988-07-26 1992-06-16 Fidia Farmaceutici Sintesi di derivati di glicosfingolipidi ed in particolare di gangliosidi utilizzabili per la preparazione di immunoadsorbenti ed adsorbenti per affinita' impiegabili per la purificazione di anticorpi e di tossine specifiche, e per uso diagnostico
US5149782A (en) * 1988-08-19 1992-09-22 Tanox Biosystems, Inc. Molecular conjugates containing cell membrane-blending agents
DE3840044A1 (de) * 1988-11-27 1990-06-07 Behringwerke Ag Glykosphingolipide mit kopplungsfaehiger gruppe im sphingoidanteil, ihre herstellung und verwendung
US6407072B1 (en) * 1988-12-02 2002-06-18 Fidia S.P.A. Lysoganglioside derivatives
IT1235161B (it) * 1988-12-02 1992-06-22 Fidia Farmaceutici Derivati di lisogangliosidi
US5192551A (en) * 1989-05-02 1993-03-09 Johns Hopkins University Neutral glycolipid as an adsorbent for enteric viral pathogens
WO1991008748A1 (en) * 1989-12-13 1991-06-27 Glycomed Incorporated Synthesis of rotavirus receptor saccharides
WO1991008747A1 (en) * 1989-12-13 1991-06-27 Glycomed Incorporated Synthetic receptor molecules recognizable by a rotavirus
US5466681A (en) * 1990-02-23 1995-11-14 Microcarb, Inc. Receptor conjugates for targeting penicillin antibiotics to bacteria
US6387884B1 (en) 1990-06-18 2002-05-14 Stanford University Leukocyte homing modulation
US6391857B1 (en) 1990-06-18 2002-05-21 Stanford University Methods and compositions for endothelial binding
JP2911554B2 (ja) * 1990-06-25 1999-06-23 台糖株式会社 抗ウィルス剤
CA2065265A1 (en) * 1990-06-27 1991-12-28 Tadao Shoji Alkylated oligosaccharides and acetyl derivatives of the same
JPH06501383A (ja) * 1990-08-02 1994-02-17 マイクロカーブ　インク 病原体又は日和見感染微生物に対する接着受容体
US5843463A (en) * 1990-12-21 1998-12-01 Antexbiologics, Inc. Adhesin-oligosaccharide conjugate vaccine for Haemophilus influenzae
ATE124262T1 (de) * 1990-12-21 1995-07-15 Microcarb Inc Verwendung von wirtszellphospholipiden zur hemmung bakterieller besiedlung.
US6121233A (en) 1991-04-19 2000-09-19 John L. Magnani Methods for the inhibition of cancer metastasis mediated by endothelial adhesion molecules
US5936076A (en) * 1991-08-29 1999-08-10 Kirin Beer Kabushiki Kaisha αgalactosylceramide derivatives
JPH05279381A (ja) * 1991-09-13 1993-10-26 Dainippon Ink & Chem Inc 硫酸化オリゴ糖芳香族配糖体
GB9219562D0 (en) 1992-03-11 1992-10-28 Prendergast Kennet F Anti-viral peptides
TW261533B (de) * 1992-07-16 1995-11-01 Kirin Brewery
US5849716A (en) * 1992-10-22 1998-12-15 Kirin Beer Kabushiki Kaisha Sphingoglycolipids, their preparation, and therapeutic methods of use
EP0680337A4 (de) * 1993-01-12 1997-07-30 Anthony George Gristina Methoden und zusammensetzungen zur direkter konzentrierter verabreichung passiver immunität.
WO1994024142A1 (en) * 1993-04-15 1994-10-27 Kirin Beer Kabushiki Kaisha Novel sphingoglycolipid and use thereof
CA2171614C (en) * 1994-07-15 2008-04-15 Mamoru Koketsu Pharmaceutical composition containing sialic acid derivatives
US5606512A (en) * 1994-07-27 1997-02-25 The Dow Chemical Company Determining the biodegradability of iminodiacetic acid derivatives
DE69515671T3 (de) * 1994-07-27 2004-06-17 The Dow Chemical Co., Midland Bestimmung der biodegradabilität von asparaginsäurederivaten, abbaubare chelatbildner, verwendungen und zusammensetzungen davon
US5730157A (en) * 1995-12-07 1998-03-24 Clarion Pharmaceuticals Inc. Method for treating viral infection
US5973128A (en) * 1996-11-22 1999-10-26 The Hospital For Sick Children Research And Development Lp Glycolipid mimics and methods of use thereof
US6083921A (en) * 1998-01-12 2000-07-04 Xu; Kai Jian Pharmaceutical compositions and method of using same
CA2359839A1 (en) * 1999-02-23 2000-08-31 Takara Shuzo Co., Ltd. Sulfated fucogalactan
SE9904581D0 (sv) * 1999-12-15 1999-12-15 A & Science Invest Ab A novel helicobacter pylori-binding substance and use thereof
US7135173B2 (en) * 2000-07-13 2006-11-14 Idaho Research Foundation, Inc. Antiviral activity of Shiga toxin
US6541013B1 (en) 2000-07-13 2003-04-01 Idaho Research Foundation, Inc. Methods and compositions for suppressing bovine leukemia virus with a Shiga toxin polypeptide
DE60232077D1 (de) * 2001-06-29 2009-06-04 Glykos Finland Oy Verwendung mindestens einer glycoinhibitor-substanz gegen infektionskrankheiten
FI20011403A (fi) * 2001-06-29 2002-12-30 Carbion Oy Menetelmä ja koostumukset vatsan sairauksien hoitoon
US7865047B2 (en) * 2001-12-28 2011-01-04 Prysmian Cavi E Sistemi Energia S.R.L. Water-resistant telecommunication cable
AU2003249641B2 (en) 2002-05-16 2009-08-20 Glycomimetics, Inc. Compounds and methods for inhibiting selectin-mediated function
US20040096396A1 (en) * 2002-07-03 2004-05-20 Glycomimetics, Inc. Compositions and methods for diagnosis and therapy of medical conditions involving angiogenesis
CN1705488A (zh) * 2002-10-22 2005-12-07 独立行政法人科学技术振兴机构 登革热病毒感染抑制剂
PL377161A1 (pl) * 2002-11-21 2006-01-23 Pevion Biotech Ltd. Wysoce efektywne pęcherzyki fuzogenne, sposób ich wytwarzania oraz kompozycje farmaceutyczne zawierające te pęcherzyki
US20040219158A1 (en) * 2003-05-02 2004-11-04 Glycomimetics, Inc. Compositions and methods for diagnosis and therapy of medical conditions involving infection with pseudomonas bacteria
CA2546784A1 (en) * 2003-11-19 2005-06-16 Glycomimetics, Inc. Glycomimetic antagonists for both e- and p-selectins
US7361644B2 (en) * 2003-11-19 2008-04-22 Glycomimetics, Inc. Specific antagonist for both E- and P-selectins
US8137397B2 (en) * 2004-02-26 2012-03-20 Boston Scientific Scimed, Inc. Medical devices
US8201377B2 (en) * 2004-11-05 2012-06-19 Faus Group, Inc. Flooring system having multiple alignment points
US20090036386A1 (en) * 2005-05-25 2009-02-05 Glycomimetics, Inc Heterobifunctional compounds for selectin inhibition
ATE528311T1 (de) * 2005-08-09 2011-10-15 Glycomimetics Inc Glycomimetische inhibitoren des pa-il-lectins, pa-iil-lectins oder beider lectine aus pseudomonas
PT2264043T (pt) * 2005-09-02 2018-01-19 Glycomimetics Inc Inibidores de pan-selectina heterobifuncionais
WO2007143052A1 (en) * 2006-06-01 2007-12-13 Glycomimetics, Inc. Galactosides and thiodigalactosides as inhibitors of pa-il lectin from pseudomonas
WO2008060378A2 (en) * 2006-10-12 2008-05-22 Glycomimetics, Inc. Glycomimetic replacements for hexoses and n-acetyl hexosamines
JP5511390B2 (ja) * 2007-02-09 2014-06-04 グリコミメティクス， インコーポレイテッド ヘキソースおよびｎ−アセチルヘキソサミンの置換体を有する糖模倣体の使用方法
US8039442B2 (en) * 2007-07-18 2011-10-18 Glycomimetics, Inc. Compounds and methods for treatment of sickle cell disease or complications associated therewith
WO2009126556A1 (en) 2008-04-08 2009-10-15 Glycomimetics, Inc. Pan-selectin inhibitor with enhanced pharmacokinetic activity
CA2727788A1 (en) * 2008-06-13 2009-12-17 Glycomimetics, Inc. Treatment of cancers of the blood using selected glycomimetic compounds
CA2760292A1 (en) * 2009-05-01 2010-11-04 Glycomimetics, Inc. Heterobifunctional inhibitors of e-selectins and cxcr4 chemokine receptors
WO2012037034A1 (en) 2010-09-14 2012-03-22 Glycomimetics, Inc. E-selectin antagonists
PT2794626T (pt) 2011-12-22 2018-01-12 Glycomimetics Inc Compostos de antagonistas de e-selectina
SI2928476T1 (en) 2012-12-07 2018-06-29 Glycomimetics, Inc. COMPONENTS, INSTALLATIONS AND PROCEDURES OF THE APPLICATION OF E-SELECTINE OF ANTAGONISTS FOR THE MOBILIZATION OF HEMATOPOETIC CELLS
HUE045542T2 (hu) 2014-12-03 2019-12-30 Glycomimetics Inc E-szelektinek és CXCR4 kemokin receptorok heterobifunkcionális inhibitorai
CA3009836A1 (en) 2016-01-22 2017-07-27 Glycomimetics, Inc. Glycomimetic inhibitors of pa-il and pa-iil lectins
WO2017151708A1 (en) 2016-03-02 2017-09-08 Glycomimetics, Inc. Methods for the treatment and/or prevention of cardiovescular disease by inhibition of e-selectin
EP3497131B1 (de) 2016-08-08 2022-03-09 GlycoMimetics, Inc. Kombination von t-zell-checkpoint-inhibitoren mit e-selectin- oder cxcr4-inhibitoren oder mit heterobifunktionellen e-selectin- wie auch cxcr4-inhibitoren
KR102653723B1 (ko) 2016-10-07 2024-04-01 글리코미메틱스, 인크. 매우 강력한 다량체성 e-셀렉틴 길항물질
US11197877B2 (en) 2017-03-15 2021-12-14 Glycomimetics. Inc. Galactopyranosyl-cyclohexyl derivauves as E-selectin antagonists
EP3717013A1 (de) 2017-11-30 2020-10-07 GlycoMimetics, Inc. Verfahren zur mobilisierung von knochenmarkinfiltrierenden lymphozyten und deren verwendung
WO2019133878A1 (en) 2017-12-29 2019-07-04 Glycomimetics, Inc. Heterobifunctional inhibitors of e-selectin and galectin-3
JP7455064B2 (ja) 2018-03-05 2024-03-25 グリコミメティクス， インコーポレイテッド 急性骨髄性白血病および関連状態を処置する方法
WO2020139962A1 (en) 2018-12-27 2020-07-02 Glycomimetics, Inc. Heterobifunctional inhibitors of e-selectin and galectin-3
CN114920788B (zh) * 2022-05-30 2024-07-30 天津科技大学 人乳三糖半乳糖基乳糖的制备

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3622666A (en) * 1968-03-04 1971-11-23 Stanley Drug Products Inc Methods for treating bacterial infections with phrenosin
DE1910715A1 (de) * 1968-03-04 1969-10-09 Stanley Drug Products Inc Antimikrobielle Faktoren und deren Verwendung
DE2322562C2 (de) * 1972-11-06 1984-03-29 Pharmacia AB, Uppsala Verfahren zur Bestimmung von Antigenen in einer Probe
US4056322A (en) * 1973-12-14 1977-11-01 Strategic Medical Research Corporation Preparation of ethers of monosaccharides
US4397844A (en) * 1978-02-24 1983-08-09 Ciba-Geigy Corporation Antigen derivatives and processes for their preparation
FR2478104B1 (fr) * 1980-03-17 1986-08-08 Merieux Inst Nouveaux derives de gangliosides, leur preparation et leur application
US4397959A (en) * 1980-11-05 1983-08-09 Research Corporation Forced precipitation method for preparing antigen/antibody particles
US4476119A (en) * 1981-08-04 1984-10-09 Fidia S.P.A. Method for preparing ganglioside derivatives and use thereof in pharmaceutical compositions
AU561067B2 (en) * 1982-03-22 1987-04-30 Biocarb Ab Anti-bacterial composition containing an oligosaccharide
US4678747A (en) * 1983-02-18 1987-07-07 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies for detection of an H (O) blood group antigen
SE8304007D0 (sv) * 1983-07-15 1983-07-15 Karlsson Karl Anders Forening och komposition for terapeutisk eller diagnostisk anvendning samt forfarande for terapeutisk behandling
IT1168205B (it) * 1983-07-21 1987-05-20 Wellcome Italia Derivato di monsialo ganglioside dotato di attivita' antibatterica, antifungina ed antitumorale, composizioni che lo contengono e procedimento per la loro preparazione
EP0146810A3 (de) * 1983-12-05 1987-05-13 Solco Basel AG Verfahren zur Herstellung von Sphingosinderivaten
US4695553A (en) * 1985-11-01 1987-09-22 Becton Dickinson And Co., Inc. Method for increasing agglutination of groups of cells to produce improved cell layer interface in centrifuged blood sample using antibodies

Also Published As

Publication number Publication date
FI93227C (fi) 1995-03-10
EP0207984B1 (de) 1991-07-03
FI863702A0 (fi) 1986-09-12
AU5351386A (en) 1986-07-29
IL77603A (en) 1994-12-29
AU580136B2 (en) 1989-01-05
EP0207984A1 (de) 1987-01-14
NO863646D0 (no) 1986-09-12
JPS62502260A (ja) 1987-09-03
US4980462A (en) 1990-12-25
FI863702A (fi) 1986-09-12
WO1986003971A1 (en) 1986-07-17
FI93227B (fi) 1994-11-30
US4859769A (en) 1989-08-22
IE59036B1 (en) 1993-12-15
NO173298B (no) 1993-08-16
CN86100608A (zh) 1987-02-18
NO863646L (no) 1986-11-14
IE860075L (en) 1986-07-14
DK17885D0 (da) 1985-01-14

Similar Documents

Publication Publication Date Title
NO173298C (no) Anvendelse av karbohydratforbindelse med virusbindende egenskaper for in vitro diagnose av virusinfeksjoner eller for fremstilling eller isolering av viruspartikler eller virusoverflatekomponenter
EP0192001A3 (en) Papilloma virus probes and in vitro methods for the diagnosis of papilloma virus infections
IT1196032B (it) Procedimento per la preparazione di vaccini polivalenti adsrobiti liofilizzati
LV10654B (en) Method for preparation of diagnostic composition and the use thereof
MX5712A (es) Procedimiento para la preparacion de compuestos esteroides y compuestos obtenidos
IT1131109B (it) Procedimento per la preparazione di concentrati di complesso portrombinico ad alta purezza e concentrati ottenuti
DK130983D0 (da) Fremgangsmade til fremstilling af terapeutiske eller diagnostiske praeparater
DK131083D0 (da) Fremgangsmade til fremstilling af terapeutiske eller diagnostiske praeparater
NO880935D0 (no) Fremgangmsaate for paavisning av hiv eller annet virus med lignende klinisk virkning.
ZA813479B (en) Process for the isolation of viral glycoproteic antigens and its application to the preparation of vaccines
PT87004A (pt) Process for the preparation of compositions for the treatment of viral infections and composites 3'-azide-2',3'-didesoxy-in osine and 3'-fluoro-2',3'-didesoxyguanosine
GB2199038B (en) Immunologically active polypeptides useful for the preparation of antimalarial vaccines and of diagnostic kits for the detection of antisporozoite antibodies
FR2585326B3 (fr) Configuration d'arriere de fuselage d'avion
IT1191849B (it) Procedimento per la preparazione di chetoni
IT1223485B (it) Procedimento per la preparazione di componenti ceramici
PT83787B (en) Improved process for the laboratory diagnosis of infections caused by htlv 222 virus in particular
GB2199326B (en) Polypeptidic composition useful for the preparation of antimalarial vaccines and of diagnostic kits for the detection of antimerozoite antibodies
IT8368106A0 (it) Dispositivo di filtraggio per l aria di aspirazione di motori di aeromobili in particolare elicotteri
ZA874778B (en) Polypeptide useful for the preparation of antimalarial vaccines and of diagnostic kits for the detection of malarial affections
IT8048117A0 (it) Composizione per il trattamento di infezioni virali e procedimento di preparazione
IT7948752A0 (it) Vaccino per il virus della parainfluenza e suo procedimento di preparazione
IT1157531B (it) Procedimento per la preparazione di bevande calde mediante l'uso preferibilmente di sostanze solubili o liofilizzate
DK397583D0 (da) Fremgangsmade til fremstilling af 1-substituerede cycliske lactam-2-carboxylsyrer eller derivater deraf
ES555070A0 (es) Procedimiento para la preparacion y construccion de suelos elasticos
IE860983L (en) Antigens related to envelope glycoprotein of the virus of¹aids